CAV1 and posterior cortical atrophy: In conclusion, when combining traditional clinical features and using the power of radiotranscriptomics, the identified biomarkers (SNAI2, CAV1, RD5A2, RND3, miR205‐5p, miR205‐3p, and miR221‐3p) could improve the accuracy of predicting PCa.